The Dis-Chem Foundation launched its first hydroponic vegetable garden, marking an important step in its commitment to address nutritional needs within underprivileged communities in the country.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Investors in Biogen Inc (Symbol: BIIB) saw new options begin trading today, for the January 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB ...
In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other healthcare stocks. The healthcare industry remains a vital and resilient sector which is ...
Biogen has added a preclinical-stage drug candidate for Parkinson's disease via a $722.5 million licensing agreement with Alectos Therapeutic, as it continues to rebuild a pipeline behind its side ...
Cambridge, Massachusetts-based Biogen Inc. (BIIB) discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. With a market cap of $23 bill ...
Last year, the first phase 3 trial of Sage Therapeutics and Biogen's antidepressant hopeful zuranolone hit its efficacy targets, but raised doubts about the durability of the response. Now ...
Moana 2 returns $57.5 million on Thanksgiving Day, setting a new box office record for Disney (DIS). Experts are expecting a record-breaking Thanksgiving box office due to the combination of Moana ...
207940.KS Samsung Biologics Co.,Ltd.
Scott Disick found it “disrespectful” that Kristin Cavallari exposed his private DM to her — and called out the peculiar timing of when he sent it — on her podcast Tuesday, a source ...
Since IPO, Disney stock has been traded on the New York Stock Exchange under the ticker symbol DIS, it has been one of the 30 stocks in the Dow Jones industrial average since 1991. Disney’s ...
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA ...